Facebook
Twitter
LinkedIn
ForwardQIPS Leadership Development Program Session: Making the Business Case for Quality
IMPORTANT BROWSER INFORMATION |
|---|
This site will not work on Internet Explorer 8. Please use: |
The absence of a "business case" for improving the quality of health care is one of the most important obstacles to improving health care in the United States. The creation of a business case for quality is central to improving the functioning of our health care system. It will require a leadership trained and practiced in analyzing the business case for quality. The value of proposed quality improvement needs to be thoughtfully and effectively assessed and prioritized. Organizations that consider a broad range of business case arguments will make more effective use of their limited resources. An effort to create a business case for quality has to be strategic, realistic, and organized for the long haul.
Participants will learn the concepts and applications of developing a business case for quality improvement.
Successful Completion
To successfully complete this activity, the required evaluation must be completed no later than Monday, January 18, 2021. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.
Target Audience
This program is targeted to physicians, physician assistants, nurse practitioners, nurses, and other healthcare professionals.
Learning Objectives
After completing this educational activity, learners will be able to:
- Analyze the cost of poor quality
- Estimate the value of a proposed change in practice
- List barriers to achieving stakeholder buy-in for quality and safety improvement projects
- Use best practice to formally present a business case
Commercial/In-Kind Support
This educational activity has no commercial or in-kind support.
Preliminary Program Agenda
This activity will be a live virtual meeting.
Thomas Jefferson University endorses the ACCME Standards for Commercial Support: Standards to Ensure Independence in CME Activities and the policies that supplement the Standards. All planners, faculty, authors, presenters, and content reviewers are required to disclose any relevant financial relationships with ACCME defined commercial interest entities within the past 12 months. Any conflict of interests have been resolved prior to this educational activity.
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the US FDA for the treatment of disease(s).
Such disclosures will be available prior to the start of the activity. Jefferson Conflict of Interest resolution process may result in changes to the program agenda.
PLANNING COMMITTEE
No member of the planning committee have any conflict of interest to disclose.
Mary Reich Cooper, MD JD-Activity Director
Ellen Guarnieri, RN, MHSA, CPHQ, FACHE
Richard Hass, PhD
PRESENTERS
The following presenters have no conflict interest to disclose.
Peter DeAngelis, jr.
Jonathan Gleason, MD
Monica Doyle
Richard Kwei
Kate Behan, MD
Joyce Kim
Mary Reich Cooper, MD JD
Ellen Guarnieri, RN, MHSA, CPHQ, FACHE
Off‐label/Investigational Use
This activity does not contain information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.
Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices, or Thomas Jefferson University, or the Joint Provider(s).
It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.
In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CREDIT DESIGNATION
Physicians: The Thomas Jefferson University designates this educational activity for a maximum of 3.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: This activity awards 3.00 nursing contact hours.
Other Healthcare Professionals: This educational activity is designated for 3.00 AMA PRA Category 1 Credits™.
Available Credit
- 3.00 AMA PRA Category 1 Credit™
- 3.00 Attendance
- 3.00 CNE
Price
REGISTRATION
For more information and to register for this course, visit the Jefferson College of Population Health web page